Hyderabad, India and Princeton, NJ, USA. February 22, 2021— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Lansoprazole DR Orally Disintegrating Tablets a therapeutic equivalent generic version of Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets, 15 mg […]
Press
Hunjan Hospital launches Mako Robotic Arm-Assisted Technology for knee replacement in Ludhiana
Feb 20, 2021 | Ludhiana: Ludhiana reached an important milestone in knee replacement as it became the first city in Northern India to have the world’s most widely adopted US FDA approved Mako Robotic Arm-Assisted Technology. The first Mako System in Northern India has been installed at Hunjan Hospital, said a press release issued jointly […]
All you need to know about Breast Cancer
World Cancer Day 2021: All you need to know about Breast Cancer The most common cancer amongst women, breast cancer covers 25% of all cancer burden, globally as well as in India. With alarming rise in its incidence in the country, predominantly in urban India, estimates suggest every four minutes an Indian woman is diagnosed […]
Wolters Kluwer and ICC accentuate the need of Evidence-Based Medicine practice to provide quality care
Virtual conference on the need to adopt technologically integrated EBM practice Today’s healthcare ecosystem needs to be technologically integrated for clinicians to provide standardized care to their patient for better outcomes. The Covid-19 pandemic has brought a great havoc to the world, but it has been a driving force in adoption of digital technologies which […]
A vaccine for all mankind: Sputnik V’s efficacy in fighting COVID-19 is validated by internationally peer reviewed data published in The Lancet
In an interim analysis of a Phase III clinical trial, Sputnik V showed strong efficacy, immunogenicity and safety results. Efficacy of Sputnik V against COVID-19 was reported at 91.6%. Analysis included data on 19,866 volunteers, who received both the first and second doses of the Sputnik V vaccine or placebo at the final control point […]
Novartis renews WHO medicine donation pledge with aim of ending leprosy
Novartis leprosy medicine donation program with WHO extended to 2025 Program has already treated over 7 million patients since 2000 New evidence from contact tracing and preventive treatment program shows route to accelerate elimination Basel, January 29, 2021 — A renewed partnership agreement signed by Novartis and the World Health Organization (WHO) will drive the […]
Health insurance policies to cover Peritoneal Dialysis to reduce dialysis burden in India
To address the increasing number of Kidney Failure patients in India, the Insurance Regulatory Development Authority of India (IRDAI) has released the much-awaited policy guidelines to include Peritoneal Dialysis (PD)in the ambit of private insurance coverage. According to the guidelines, patients taking treatment of PD can make reimbursement claims on a monthly basis through an […]
Experts underscore uncertainty about AstraZeneca’s dosage and efficacy
This weekend’s approval of AstraZeneca’s vaccine by the Drugs Controller General of India has stirred some controversy in the public and the scientific community. Apart from the most obvious point – the vaccine, developed by AstraZeneca and Oxford University showed only 62.1 percent efficacy, much lower than other major vaccines already approved for use in […]
CCIL president T. M. Chen on pollution, air quality, and health
Air pollution is among the most pressing challenges in creating a healthy society. It has been a bane on Indians’ public health for decades as the State of Global Air Report 2020 underlined. To discuss this, Health Issues India spoke with T. M. Chen, president of Continental Carbon India Limited (CCIL) and Master of Chemical Engineering […]
Bayer partners with Arogya Finance to provide Eylea Easy Pay Program in India
Bayer partners with Arogya Finance to introduce the Eylea Easy Pay Program in India, with an aim to improve patient adherence and increase access to the innovative treatment solution Eylea. The program will be available in eye hospitals across the country. Eylea, or Aflibercept solution, is indicated for the treatment of Diabetic Macular Edema (DME) […]